Marker Therapeutics, Inc.MRKRNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P0
Near historical low
vs 3Y Ago
-97653961.3x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-110116528.98%
202433.64%
202339.05%
20221.13%
2021-36.16%
2020-9.57%
2019-26.27%
2018-71.57%
2017-29.64%
2016-49.88%